We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8060:TSECanon Marketing Japan Incorporated Analysis

Data as of 2026-03-17 - not real-time

¥6,924.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Canon Marketing Japan Inc. is trading just above its 20‑day (¥6,884) and 50‑day (¥6,892) simple moving averages, with a neutral RSI of 51 and a bullish MACD crossover, indicating short‑term momentum is modestly positive. Valuation metrics are attractive: the trailing P/E of 18 is well below the industry average of 29, and the DCF‑derived fair value suggests a potential upside of roughly 13% relative to current levels. Dividend sustainability looks solid, with a 2.5% yield and a payout ratio under 45%, supported by ample cash (¥160 bn) and low leverage (debt‑to‑equity 0.76).
The stock exhibits low systematic risk (beta 0.37) and a manageable 30‑day volatility of 22%, while operating in a stable industrial segment. With stable volume, clear support at ¥6,612 and resistance near ¥7,090, the price action aligns with a neutral to slightly bullish outlook, making the company a compelling buy for investors seeking a blend of value and modest growth.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD histogram confirming short‑term momentum
  • Price holding above 20‑day and 50‑day SMAs
  • Support level at ¥6,612 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued P/E relative to industry peers
  • DCF upside potential of ~13% and attractive dividend yield
  • Low beta indicating defensive characteristics in a volatile market

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong cash generation and low leverage supporting dividend sustainability
  • Stable sector dynamics with consistent demand for business equipment
  • Long‑term growth prospects from diversified product segments and corporate solutions

Key Metrics & Analysis

Financial Health

Revenue Growth4.00%
Profit Margin6.10%
P/E Ratio18.2
ROE10.42%
ROA6.68%
Debt/Equity0.76
P/B Ratio1.8
Op. Cash Flow¥45.9B
Free Cash Flow¥77.6B
Industry P/E29.3

Technical Analysis

TrendNeutral
RSI51.3
Support¥6,612.00
Resistance¥7,090.00
MA 20¥6,884.25
MA 50¥6,892.32
MA 200¥6,155.63
MACDBullish
VolumeStable
Fear & Greed Index79.45

Valuation

Fair Value¥13,135.88
Target Price¥7,866.67
Upside/Downside13.61%
GradeUndervalued
TypeBlend
Dividend Yield2.51%

Risk Assessment

Beta0.37
Volatility21.96%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.